id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
712,,,,,,,,,,,,,,,2024-06-01T14:25:52+06:00,BSH - H11908045393,Right,Tamoxifen,2023-01-14,,"Started Adjuvant chemo with AC, C1 from 14.09.2019 & Cycle 4 comepleted on 16/11/19.
Cycle 5 started with Paclitaxel on 07/12/19, C8 due on 8.02.2020.",2024-02-05,,2024-02-08,,2020-09-21,2020-09-21,2019-12-04,Breast,130,Upper middle class,BSBSC-240000130,NILIMA BHOWMIK,1912494492,1966-02-01,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,Continuous Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Right,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,CA15.3,7.1,,2022-05-21,712.0
712,,,,,,,,,,,,,,,2024-06-01T14:25:52+06:00,BSH - H11908045393,Right,Tamoxifen,2023-01-14,,"Started Adjuvant chemo with AC, C1 from 14.09.2019 & Cycle 4 comepleted on 16/11/19.
Cycle 5 started with Paclitaxel on 07/12/19, C8 due on 8.02.2020.",2024-02-05,,2024-02-08,,2020-09-21,2020-09-21,2019-12-04,Breast,130,Upper middle class,BSBSC-240000130,NILIMA BHOWMIK,1912494492,1966-02-01,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,Continuous Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Right,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,CA15.3,10.7,,2022-07-10,712.0
712,,,,,,,,,,,,,,,2024-06-01T14:25:52+06:00,BSH - H11908045393,Right,Tamoxifen,2023-01-14,,"Started Adjuvant chemo with AC, C1 from 14.09.2019 & Cycle 4 comepleted on 16/11/19.
Cycle 5 started with Paclitaxel on 07/12/19, C8 due on 8.02.2020.",2024-02-05,,2024-02-08,,2020-09-21,2020-09-21,2019-12-04,Breast,130,Upper middle class,BSBSC-240000130,NILIMA BHOWMIK,1912494492,1966-02-01,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,Continuous Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Right,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,CA15.3,11.9,,2023-01-13,712.0
712,,,,,,,,,,,,,,,2024-06-01T14:25:52+06:00,BSH - H11908045393,Right,Tamoxifen,2023-01-14,,"Started Adjuvant chemo with AC, C1 from 14.09.2019 & Cycle 4 comepleted on 16/11/19.
Cycle 5 started with Paclitaxel on 07/12/19, C8 due on 8.02.2020.",2024-02-05,,2024-02-08,,2020-09-21,2020-09-21,2019-12-04,Breast,130,Upper middle class,BSBSC-240000130,NILIMA BHOWMIK,1912494492,1966-02-01,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,Continuous Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Right,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,CA15.3,8.1,,2023-07-23,712.0
712,,,,,,,,,,,,,,,2024-06-01T14:25:52+06:00,BSH - H11908045393,Right,Tamoxifen,2023-01-14,,"Started Adjuvant chemo with AC, C1 from 14.09.2019 & Cycle 4 comepleted on 16/11/19.
Cycle 5 started with Paclitaxel on 07/12/19, C8 due on 8.02.2020.",2024-02-05,,2024-02-08,,2020-09-21,2020-09-21,2019-12-04,Breast,130,Upper middle class,BSBSC-240000130,NILIMA BHOWMIK,1912494492,1966-02-01,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,Continuous Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Right,,,Stable,Alive,CR,,,,CR,,,,,,,CR,,,,,,CA15.3,8.2,,2024-02-05,712.0
